<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02789748</url>
  </required_header>
  <id_info>
    <org_study_id>IAHO03</org_study_id>
    <nct_id>NCT02789748</nct_id>
  </id_info>
  <brief_title>PErsonalized and Adaptive Kinesthetic stImulation Therapy, Based on Cardio-respiratory Holter moNitoring, for Sleep Apnea syndrOmes</brief_title>
  <acronym>EKINOx</acronym>
  <sponsors>
    <lead_sponsor>
      <agency>LivaNova</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>National Research Agency, France</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>LivaNova</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study aims at quantifying the performance of kinesthetic stimulation to reduce the&#xD;
      burden of obstructive sleep apneas and hypopneas.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Severe sleep apnea patients will undergo two polysomnographies (PSG), one with kinesthetic&#xD;
      stimulation triggered on the detection of apneas and hypopneas (treated night ) and the other&#xD;
      without kinesthetic stimulation (non-treated night ). Comparison of apnea and hypopnea&#xD;
      indices (AHI) and of oxygen saturation between the treated and non-treated night will be&#xD;
      taken as indicators to quantify the performance of this potential new therapy.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">June 1, 2016</start_date>
  <completion_date type="Actual">October 2, 2017</completion_date>
  <primary_completion_date type="Actual">October 2, 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of responder to the therapy</measure>
    <time_frame>Day 1 post-discharge</time_frame>
    <description>A patient is defined as 'responder' to the therapy by comparison of the treated night to the non-treated night based on:&#xD;
The oxygen desaturation index (ODI)&#xD;
The time spent below 90% of oxygen saturation or&#xD;
The apnea hypopnea index (AHI) reduction</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Adverse device effect</measure>
    <time_frame>Day 1 post-discharge</time_frame>
    <description>Adverse Events related to the investigational device</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect on apneas/hypopneas duration</measure>
    <time_frame>Day 1 post-discharge</time_frame>
    <description>Therapy effect on shortening respiratory events</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect on modified apnea hypopnea index</measure>
    <time_frame>Day 1 post-discharge</time_frame>
    <description>The modified apnea hypopnea indices (AHIs) will be compared between the treated and non-treated night and defined based on the duration of the respiratory disorders</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Instantaneous heart rate measurement (bpm) during the night ON and the night OFF</measure>
    <time_frame>Day 1 post-discharge</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of arousals per night - comparison night ON and night OFF</measure>
    <time_frame>Day 1 post-discharge</time_frame>
    <description>The micro-arousal index will be calculated on the polysomnography recording.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Effect on an objective measure of somnolence (Osler)</measure>
    <time_frame>Day 1 post-discharge</time_frame>
    <description>Osler test (optional) performed after treated night and non-treated night</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">42</enrollment>
  <condition>Obstructive Sleep Apnea Syndrome</condition>
  <arm_group>
    <arm_group_label>Treatment ON</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Kinesthetic stimulation administered during one night</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Treatment OFF</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>NO kinesthetic stimulation administered during one night</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Kinesthetic stimulation</intervention_name>
    <description>Activation of mechanoreceptors by vibration bursts</description>
    <arm_group_label>Treatment ON</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Patients who meet all the following criteria at the time of enrollment may be included:&#xD;
&#xD;
          -  Man or woman aged more than 18 years old.&#xD;
&#xD;
          -  Patient with severe obstructive apnea syndrome diagnosed on polysomnography or&#xD;
             polygraphy performed less than 6 months ago with (AHI &gt; 30/h and 80% of obstructive&#xD;
             events) and (ODI 4% &gt; 20 or time with SaO2 below 90% &gt; 5%).&#xD;
&#xD;
          -  Patient free from continuous positive airway pressure (CPAP) treatment or any other&#xD;
             SAS treatment for at least 3 months&#xD;
&#xD;
          -  Patient with no psychrotropic medication or stable psychotropic medication since the&#xD;
             diagnostic polysomnography or polygraphy examination&#xD;
&#xD;
          -  Patient was informed and has signed the informed consent&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        Patients who meet any one of these criteria will be excluded from the study:&#xD;
&#xD;
          -  Patients sleeping less than 4 hours per night&#xD;
&#xD;
          -  Patients suffering from respiratory failure, such as chronic obstructive pulmonary&#xD;
             disease (COPD), pneumonia, pulmonary edema, pulmonary fibrosis, asthma, pulmonary&#xD;
             arterial hypertension.&#xD;
&#xD;
          -  Patients developing periodic breathing or Cheyne Stokes respiration&#xD;
&#xD;
          -  Obese patient (BMI&gt;35kg/m2)&#xD;
&#xD;
          -  Patient with autonomic dysfunction (symptoms include orthostatic hypotension, exercise&#xD;
             intolerance, sweating abnormalities, digestion difficulties, urinary problems, vision&#xD;
             problems) as complication of diabetes, Parkinson's disease or other primary&#xD;
             pathologies.&#xD;
&#xD;
          -  Patient suffering from restless leg syndrome or periodic leg movement (PLM) not&#xD;
             related to obstructive sleep apnea, i.e. PLM index &gt; 15/h excluding movements linked&#xD;
             to respiratory events.&#xD;
&#xD;
          -  Patient suffering from positional sleep apnea syndrome (SAS), i.e. supine apnea&#xD;
             hypopnea index (AHI) at least twice that of the non-supine AHI&#xD;
&#xD;
          -  Patient suffering from severe peripheral neuropathy&#xD;
&#xD;
          -  Vulnerable patient in accordance with article L1121-6 of Code de la Sant√© Publique&#xD;
             (CSP)&#xD;
&#xD;
          -  Patient already involved in another clinical study that could affect the result of&#xD;
             this study&#xD;
&#xD;
          -  Pregnant patient&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Hospital Beziers</name>
      <address>
        <city>Beziers</city>
        <zip>34500</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Grenoble</name>
      <address>
        <city>Grenoble</city>
        <zip>38043</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>CHU Rennes</name>
      <address>
        <city>Rennes</city>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Tours</name>
      <address>
        <city>Tours</city>
        <zip>37 044</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>October 2017</verification_date>
  <study_first_submitted>February 18, 2016</study_first_submitted>
  <study_first_submitted_qc>May 30, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 3, 2016</study_first_posted>
  <last_update_submitted>October 3, 2017</last_update_submitted>
  <last_update_submitted_qc>October 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Sleep Apnea Syndromes</mesh_term>
    <mesh_term>Sleep Apnea, Obstructive</mesh_term>
    <mesh_term>Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

